Cancer Diagnostics Market Analysis, Size, Growth, Share, Outlook & Forecast to 2027 | Grand View Research Inc.
The global cancer diagnostics market size is expected to reach USD 249.6 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a 7.0% during the forecast period. Continual introduction of innovative products, coupled with increasing need for early diagnosis of various diseases, is a prime factor driving the market. In addition, rapid growth of the healthcare and diagnostics sector can be attributed to penetration of technologically advanced laboratory systems that have improved oncological screening in yielding accurate outcomes. Rising incidence of cancer is triggering demand for these screening tests and imaging modalities used for monitoring disease progression. Collaborative and independent initiatives led by governments and companies are striving to raise cognizance about the benefits of early cancer diagnosis. In addition, cancer research organizations, along with public and private entities, are investing heavily on research projects to launch advanced diagnostic tools in the market, which are capable of diagnosing the disease much before the symptoms appear. Furthermore, giant players are collaborating with governments and other agencies to enhance patient accessibility to these tests and products. For instance, Illumina, Inc. launched a new venture called GRAIL with investors, Jeff Bezos and Bill Gates, with an investment of more than USD 100 million. GRAIL is mainly focused on blood-based oncological screening for timely diagnosis of the most common tumor types through simple laboratory tests.
Further key findings from the report suggest:
Rapid adoption of technology and escalating need for early diagnosis is augmenting the growth of imaging systems. Thus, the segment is expected to exhibit the fastest CAGR at 8.0% during the forecast period
The breast cancer segment accounted for the largest share based on application due to high incidence rate of breast cancer triggering the need for its early diagnosis
In 2018, North America dominated the global space with the largest revenue share of 42.0%. Focused research efforts in oncology for development of early tumor detection tools, coupled with grants from government healthcare agencies, are contributing to a strong medical ecosystem to fight cancer in this region
Asia Pacific is expected to emerge as the fastest growing region during the forecast period. Favorable regulatory framework and growing patient pool in India, China, and Japan due to support in diagnostic process at comparatively lower prices are some of the factors boosting the market growth in this region
Major players competing in this market include GE Healthcare; Abbott; Hoffmann-La Roche Ltd.; and Siemens Healthcare GmbH. Other prominent players include but are not limited to Becton Dickinson & Company; Illumina, Inc.; Koninklijke Philips N.V.; and Hologic, Inc. Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/cancerdiagnostics-market
Grand View Research has segmented the global cancer diagnostics market on the basis of type, application, and region: Cancer Diagnostics Type Outlook (Revenue, USD Billion, 2014 - 2026)
Laboratory Tests
Genetic Tests
Imaging
Endoscopy
Biopsy
Others (barium enema)
Cancer Diagnostics Application Outlook (Revenue, USD Billion, 2014 2026)
Breast Cancer
Colorectal Cancer
Cervical Cancer
Lung Cancer
Prostate Cancer
Skin Cancer
Blood Cancer
Kidney Cancer
Liver Cancer
Pancreatic Cancer
Ovarian Cancer
Others
Cancer Diagnostics Regional Outlook (Revenue, USD Billion, 2014 - 2026)
North America o
U.S.
o
Canada
Europe o
Germany
o
U.K.
o
Spain
o
Italy
o
France
Asia Pacific o
Japan
o
China
o
India
o
Thailand
o
South Korea
Latin America o
Brazil
o
Mexico
o
Argentina
o
Columbia

Middle East and Africa (MEA) o
South Africa
o
Saudi Arabia
o
UAE
Get Sample of Report @ https://www.grandviewresearch.com/industry-analysis/cancer-diagnosticsmarket/request/rs1
Table of Content
Chapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.2. Information Procurement 1.2.1. Purchased database 1.2.2. GVR’s internal database 1.2.3. Secondary sources & third party perspectives 1.2.4. Primary research 1.3. Information Analysis 1.3.1. Data analysis models 1.4. Market Formulation & Data Visualization 1.5. Data Validation & Publishing Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Outlook 2.3. Competitive Insights
Chapter 3. Biosensors Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.1.1. Parent market outlook 3.1.2. Related/ancillary market outlook 3.2. Penetration & Growth Prospect Mapping 3.3. Product Pipeline Analysis, by Stage Continue……… About Grand View Research, Inc.: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com For More Information: http://www.grandviewresearch.com